Frontal fibrosing alopecia: A multicenter review of 355 patients
April 2014
in “Journal of The American Academy of Dermatology”
TLDR Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.
In the 2014 multicenter retrospective study of 355 patients with frontal fibrosing alopecia (FFA), researchers found that the condition predominantly affects postmenopausal women, with a mean age of 61 years, but can also occur in men and premenopausal women. Severe FFA, which involves significant recession of the frontotemporal hairline, was present in 37% of patients and was associated with eyelash loss, facial papules, and body hair involvement. Antiandrogens like finasteride and dutasteride were given to 31% of patients, with 47% showing improvement and 53% experiencing stabilization of the disease. The study suggests a hormonal role in FFA's pathogenesis, indicated by the high incidence of early menopause among patients and the response to antiandrogenic drugs. Other treatments had variable results, and the study highlights the potential for FFA to affect a broader demographic than previously thought.
View this study on jaad.org →
Cited in this study
research Is Hair Transplantation Indicated in Frontal Fibrosing Alopecia? The Results of Test Grafting in Three Patients
research Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University
Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.
research Estudio de patrones de implantación pilosa frontal en la mujer española caucásica
Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.
research Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.
research Frontal fibrosing alopecia: A review of 60 cases
Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.
research Estrogen Leads to Reversible Hair Cycle Retardation through Inducing Premature Catagen and Maintaining Telogen
Estrogen can temporarily slow down hair growth but this can be reversed.
research Frontal fibrosing alopecia: a clinical review of 36 patients
research Frontal Fibrosing Alopecia in a Man: Results of Follicular Unit Test Grafting
Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.
research Treatment of postmenopausal frontal fibrosing alopecia with oral dutasteride
Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.
research Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.
research Frontal fibrosing alopecia: clinical presentations and prognosis
research Frontal fibrosing alopecia: a survey in 16 patients
The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.
research Frontal fibrosing alopecia developing after hair transplantation for androgenetic alopecia
Hair transplant destroyed by lichen planopilaris.
research Frontal fibrosing alopecia in postmenopausal women
Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.
research Frontal fibrosing alopecia associated with cutaneous lichen planus in a premenopausal woman
research Postmenopausal frontal fibrosing alopecia: A frontal variant of lichen planopilaris
Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.
Related
research Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.
The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.
research Finasteride in The Treatment of Female Androgenic Alopecia
Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.
research Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
Finasteride 1 mg helps prevent more hair loss in men with male pattern baldness.
research Finasteride Treatment of Female Pattern Hair Loss
Finasteride with oral contraceptive improves hair loss in 62% of premenopausal women.
research Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women
Finasteride can slow hair loss and promote growth in postmenopausal women.
research Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.
research Hair loss in women with hyperandrogenism: Four cases responding to finasteride
Finasteride improves hair loss in women with hyperandrogenism.
research Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
Finasteride is effective in growing hair and stopping hair loss in men with mild to moderate alopecia.
research Finasteride in the treatment of men with frontal male pattern hair loss
Finasteride effectively treats frontal hair loss with few side effects.
research Finasteride in the treatment of men with androgenetic alopecia
Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.